Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- Latest filing
- Nov 14, 2024
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 11, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 49
- +3 vs. Q1 2021
- Portfolio value
- $319.8M
- −$37.1M (−10.4%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TBIOTelesis Bio Inc. | COM | 35,000 | $770.0K | 0.2% | +35,000 | New | History |
| PRVBProvention Bio, Inc. | COM | 100,000 | $843.0K | 0.3% | +100,000 | New | History |
| MRNAModerna, Inc. | Stock | 4,000 | $940.0K | 0.3% | +4,000 | New | History |
| LRMRLarimar Therapeutics, Inc. | COM | 100,000 | $982.0K | 0.3% | +100,000 | New | History |
| OTICOtonomy, Inc. | COM | 450,000 | $1.00M | 0.3% | 00.0% | Unchanged | History |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 650,000 | $1.01M | 0.3% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 100,000 | $1.36M | 0.4% | +100,000 | New | History |
| MRUSMerus N.V. | COM | 75,000 | $1.58M | 0.5% | +75,000 | New | History |
| CMRXChimerix Inc | COM | 200,000 | $1.60M | 0.5% | 00.0% | Unchanged | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 75,000 | $1.92M | 0.6% | +75,000 | New | History |
| CRISCuris Inc | COM NEW | 247,124 | $1.99M | 0.6% | −177,876−41.9% | Reduced | History |
| FOLDAmicus Therapeutics, Inc. | COM | 265,000 | $2.56M | 0.8% | 00.0% | Unchanged | History |
| KDMNKadmon Holdings, Inc. | COM | 800,000 | $3.10M | 1.0% | +200,000+33.3% | Added | History |
| IMUXImmunic, Inc. | COM | 265,000 | $3.25M | 1.0% | 00.0% | Unchanged | History |
| PCVXVaxcyte, Inc. | COM | 145,000 | $3.26M | 1.0% | +145,000 | New | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 125,000 | $3.53M | 1.1% | +125,000 | New | History |
| SRRASierra Oncology, Inc. | COM NEW | 200,000 | $3.89M | 1.2% | 00.0% | Unchanged | History |
| CTICCti Biopharma Corp | COM | 1,600,000 | $4.00M | 1.3% | +850,000+113.3% | Added | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 1,000,000 | $4.33M | 1.4% | 00.0% | Unchanged | History |
| ACRSAclaris Therapeutics, Inc. | COM | 250,000 | $4.39M | 1.4% | −350,000−58.3% | Reduced | History |
| ISEEIVERIC bio, Inc. | COM | 725,000 | $4.58M | 1.4% | −400,000−35.6% | Reduced | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 243,309 | $4.59M | 1.4% | +243,309 | New | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 170,000 | $4.93M | 1.5% | +170,000 | New | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 75,000 | $5.17M | 1.6% | +75,000 | New | History |
| MLTXMoonLake Immunotherapeutics | COM CL A | 500,000 | $5.17M | 1.6% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 125,000 | $5.54M | 1.7% | −200,000−61.5% | Reduced | History |
| EPIXESSA Pharma Inc. | COM NEW | 207,500 | $5.93M | 1.9% | +32,500+18.6% | Added | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 200,000 | $6.07M | 1.9% | +50,000+33.3% | Added | History |
| MRSNMersana Therapeutics, Inc. | COM | 450,000 | $6.11M | 1.9% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 2,000,000 | $6.30M | 2.0% | −2,143,702−51.7% | Reduced | History |
| STSASatsuma Pharmaceuticals, Inc. | COM | 904,225 | $6.38M | 2.0% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 350,000 | $6.40M | 2.0% | +50,000+16.7% | Added | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 1,000,000 | $6.54M | 2.0% | +60,957+6.5% | Added | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 600,000 | $6.80M | 2.1% | −50,000−7.7% | Reduced | History |
| TGTXTG Therapeutics, Inc. | COM | 180,000 | $6.98M | 2.2% | −20,000−10.0% | Reduced | History |
| ALLOAllogene Therapeutics, Inc. | COM | 275,000 | $7.17M | 2.2% | +275,000 | New | History |
| MRTXMirati Therapeutics, Inc. | COM | 50,000 | $8.08M | 2.5% | 00.0% | Unchanged | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 285,000 | $9.53M | 3.0% | +35,000+14.0% | Added | History |
| BIIBBiogen Inc. | COM | 32,500 | $11.3M | 3.5% | +12,500+62.5% | Added | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 450,000 | $11.7M | 3.7% | −50,000−10.0% | Reduced | History |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 1,250,000 | $12.1M | 3.8% | −700,000−35.9% | Reduced | – |
| COGTCogent Biosciences, Inc. | COM | 1,600,000 | $13.0M | 4.1% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 700,000 | $14.6M | 4.6% | +100,000+16.7% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 875,000 | $15.0M | 4.7% | −300,000−25.5% | Reduced | History |
| ARVNArvinas, Inc. | COM | 205,000 | $15.8M | 4.9% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 850,000 | $15.8M | 4.9% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 185,000 | $16.1M | 5.0% | 00.0% | Unchanged | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 135,000 | $17.8M | 5.6% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 570,000 | $18.1M | 5.7% | +570,000 | New | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q1 2021 (11)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 225,000 | $9.65M | 2.7% | History |
| iShares Russell 2000 ETF464287655 | ETF | 30,000 | $6.63M | 1.9% | – |
| CNSTConstellation Pharmaceuticals Inc | COM | 275,000 | $6.43M | 1.8% | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 500,000 | $5.08M | 1.4% | History |
| NUVBNuvation Bio Inc. | COM CL A | 500,000 | $4.96M | 1.4% | History |
| KYNBKyntra Bio, Inc. | COM | 125,000 | $4.34M | 1.2% | History |
| IMVTImmunovant, Inc. | COM | 250,000 | $4.01M | 1.1% | History |
| NVAXNovavax Inc | COM NEW | 17,500 | $3.17M | 0.9% | History |
| SAGESage Therapeutics, Inc. | COM | 30,000 | $2.25M | 0.6% | History |
| DTILPrecision Biosciences Inc | COM | 200,000 | $2.07M | 0.6% | History |
| APVOAptevo Therapeutics Inc. | COM NEW | 50,000 | $1.53M | 0.4% | History |